Clinical Trial Update: Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and tolerability of NOX66 in combination with palliative radiotherapy in men with late-stage prostate cancer. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• NOX66

Snippet

Sponsor: Noxopharm Limited | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2025-07-29